• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Oral non-steroidal anti-inflammatory drug use in recreational runners participating in Parkrun UK: Prevalence of use and awareness of risk
【24h】

Oral non-steroidal anti-inflammatory drug use in recreational runners participating in Parkrun UK: Prevalence of use and awareness of risk

机译：口腔非甾体抗炎药用在参加Parkrun UK的娱乐赛道：使用的流行和风险意识

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in endurance running and by elite athletes. We examined the pattern of use of NSAIDs, the purpose of use and knowledge of the adverse effects of NSAID use in a population of recreational runners at Parkrun UK. Methods An online observational non-interventional cross-sectional survey of Parkrun UK participants being over the age of 18, on Parkrun UK's mailing list, and residing in the UK. Key Findings Runners (n = 806) had a high use of NSAIDs in the past 12 months (87.8%). The average age of respondents was 48.39 years. There was a significant association between those taking an oral NSAID in the last twelve months and those with a sporting injury (chi(2) = 10.89, df = 1,n = 797,P = 0.001). Ibuprofen was the most commonly used NSAID (81.1%). A third of runners had experienced an adverse drug reaction associated with NSAIDs, usually gastrointestinal. Half of runners used NSAIDs with no advice, and patient information leaflets were the most common source for those that had advice. Ninety-four per cent of runners would like more information on the harms and benefits of NSAIDs. Conclusions Some recreational runners have a high use of NSAIDs, which is chronic in nature and a potential health risk. Recreational runners want more information on the harms and benefits of NSAIDs. Race event organizers should provide evidence-based advice on the use of NSAIDs.
机译：目的非甾体抗炎药（NSAIDs）广泛应用于耐力跑和优秀运动员。我们研究了非甾体抗炎药的使用模式、使用目的以及在英国Parkrun休闲跑步人群中使用非甾体抗炎药的不良影响。方法对18岁以上、在Parkrun UK邮寄名单上、居住在英国的Parkrun UK参与者进行在线观察性非干预性横断面调查。关键发现：在过去12个月内，跑步者（n=806）大量使用非甾体抗炎药（87.8%）。受访者的平均年龄为48.39岁。过去12个月内口服NSAID的患者与运动损伤患者之间存在显著相关性（chi（2）=10.89，df=1，n=797，P=0.001）。布洛芬是最常用的非甾体抗炎药（81.1%）。三分之一的跑步者曾经历过与非甾体抗炎药相关的不良药物反应，通常是胃肠道反应。一半的跑步者在没有建议的情况下使用非甾体抗炎药，而患者信息传单是那些有建议的人最常见的来源。94%的跑步者希望获得更多关于非甾体抗炎药的危害和益处的信息。结论一些休闲跑步者大量使用非甾体抗炎药，这是一种慢性疾病，具有潜在的健康风险。休闲跑步者想要更多关于非甾体抗炎药的危害和益处的信息。赛事组织者应就非甾体抗炎药的使用提供循证建议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号